Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

Apr 29, 2022

SELL
$38.58 - $83.27 $107,599 - $232,240
-2,789 Closed
0 $0
Q4 2021

Feb 14, 2022

SELL
$75.47 - $135.88 $104,827 - $188,737
-1,389 Reduced 33.25%
2,789 $216,000
Q3 2021

Oct 28, 2021

SELL
$95.64 - $131.48 $6,216 - $8,546
-65 Reduced 1.53%
4,178 $447,000
Q2 2021

Aug 09, 2021

SELL
$88.13 - $142.06 $2,555 - $4,119
-29 Reduced 0.68%
4,243 $565,000
Q1 2021

May 12, 2021

BUY
$105.48 - $207.97 $4,113 - $8,110
39 Added 0.92%
4,272 $529,000
Q4 2020

Feb 05, 2021

BUY
$76.64 - $167.89 $324,417 - $710,678
4,233 New
4,233 $598,000

Others Institutions Holding TWST

About Twist Bioscience Corp


  • Ticker TWST
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 56,363,500
  • Market Cap $2.57B
  • Description
  • Twist Bioscience Corporation, a synthetic biology company, manufactures and sells synthetic DNA-based products. The company's DNA synthesis platform enables the manufacturing of synthetic DNA by writing DNA on a silicon chip. It offers synthetic DNA-based products, including synthetic genes, tools for sample preparation, antibody libraries for d...
More about TWST
Track This Portfolio

Track Navellier & Associates Inc Portfolio

Follow Navellier & Associates Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Navellier & Associates Inc, based on Form 13F filings with the SEC.

News

Stay updated on Navellier & Associates Inc with notifications on news.